Seach Medical Group Ltd (TASE: SEMG)
Health Care · Pharmaceuticals · IL
₪2.79
+1.12% today · -1.0% 1Y
Seach Medical Group Ltd (TASE: SEMG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $30.01M and employs 160 people.
Over the last twelve months the share price has lost 1.0%, trading between 2.10 and 3.40.
Tweenvest scores Seach Medical Group Ltd across four factors: quality 68/100, value 68/100, dividend 90/100. Its strongest factor is dividend.
SEMG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.01M
- Revenue (TTM)
- $49.78M
- P/E
- 16.06
- EPS
- 0.17
- Dividend yield
- 6.45%
- Beta (5Y)
- 0.28
- 52-week high
- ₪3.40
- 52-week low
- ₪2.10
- Avg volume (3M)
- —
- Shares outstanding
- 32.14M
- Employees
- 160
- Next earnings
- —
About Seach Medical Group Ltd
Seach Medical Group Ltd is an Israeli company, established in 2002 and headquartered in Ramat Gan, that specializes in the global production and distribution of therapeutic cannabis products. Its offerings include medicinal cannabis flower (inflorescence) and various oil-based compounds, primarily marketed under the 'Nitzan' brand. The company's product line also extends to 'power powder' and 'moodpicks'.
- ISIN
- IL0002490113
- Founded
- 1987
- Listed since
- Feb 1, 2000
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.93 | -0.08% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.83 | -0.40% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.